KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2016 - 2025)

Gilead Sciences (GILD) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.24% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Dec 2025, changed 0.24%, and an annual FY2025 reading of $1.2 billion, changed 0.24% over the prior year.
  • Shares Outstanding (Weighted Average) was $1.2 billion for Q4 2025 at Gilead Sciences, roughly flat from $1.2 billion in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $1.3 billion in Q1 2021 and bottomed at $1.2 billion in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) increased 0.08% in 2021, then fell 0.56% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.3 billion in 2021, then fell by 0.08% to $1.3 billion in 2022, then dropped by 0.56% to $1.2 billion in 2023, then dropped by 0.08% to $1.2 billion in 2024, then fell by 0.24% to $1.2 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for GILD at $1.2 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.